Loading...
Stevanato Group S.p.A.
STVN•NYSE
Healthcare
Medical - Instruments & Supplies
$26.51
$-1.44(-5.15%)
Stevanato Group S.p.A. (STVN) Financial Performance & Income Statement Overview
Review Stevanato Group S.p.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
1.72%
↑ 1.72%
Operating Income Growth
-19.72%
↓ 19.72%
Net Income Growth
-19.13%
↓ 19.13%
Operating Cash Flow Growth
48.06%
↑ 48.06%
Operating Margin
15.16%
↑ 15.16%
Gross Margin
27.20%
↑ 27.20%
Net Profit Margin
11.16%
↑ 11.16%
ROE
9.18%
↑ 9.18%
ROIC
9.16%
↑ 9.16%
Stevanato Group S.p.A. (STVN) Income Statement & Financial Overview
Review Stevanato Group S.p.A.'s (STVN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $330.60M | $277.87M | $259.58M | $237.38M |
| Cost of Revenue | $232.44M | $203.42M | $196.20M | $178.03M |
| Gross Profit | $98.15M | $74.44M | $63.38M | $59.35M |
| Gross Profit Ratio | $0.30 | $0.27 | $0.24 | $0.25 |
| R&D Expenses | $5.57M | $6.61M | $8.74M | $9.95M |
| SG&A Expenses | $31.26M | $28.08M | $29.72M | $25.32M |
| Operating Expenses | $31.30M | $33.42M | $42.25M | $35.26M |
| Total Costs & Expenses | $263.74M | $236.84M | $231.61M | $213.30M |
| Interest Income | $81000.00 | $532000.00 | $974000.00 | $135000.00 |
| Interest Expense | $2.96M | $1.58M | $837000.00 | $1.53M |
| Depreciation & Amortization | -$22.81M | $60.95M | $20.85M | $21.79M |
| EBITDA | $67.61M | $103.32M | $50.85M | $45.88M |
| EBITDA Ratio | $0.20 | $0.37 | $0.20 | $0.19 |
| Operating Income | $66.86M | $41.03M | $27.97M | $24.09M |
| Operating Income Ratio | $0.20 | $0.15 | $0.11 | $0.10 |
| Other Income/Expenses (Net) | -$2.21M | -$237000.00 | $1.35M | $537139.00 |
| Income Before Tax | $64.65M | $40.79M | $29.32M | $25.83M |
| Income Before Tax Ratio | $0.20 | $0.15 | $0.11 | $0.11 |
| Income Tax Expense | $16.34M | $10.77M | $8.55M | $6.90M |
| Net Income | $48.31M | $30.03M | $20.63M | $18.81M |
| Net Income Ratio | $0.15 | $0.11 | $0.08 | $0.08 |
| EPS | $0.18 | $0.11 | $0.08 | $0.07 |
| Diluted EPS | $0.18 | $0.11 | $0.08 | $0.07 |
| Weighted Avg Shares Outstanding | $272.87M | $272.87M | $272.79M | $265.95M |
| Weighted Avg Shares Outstanding (Diluted) | $272.88M | $272.88M | $272.81M | $265.98M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan